Alnylam, OmniGuide, Ginger Software, and More from the Boston Deals Roundup

8/29/12Follow @xconomy

New England software makers, biotech companies, and startup incubators have been pumping out deals news in the last week.

—Westford, MA-based RiverMeadow Software, whose technology helps migrate servers to the cloud, raised $5 million of a targeted $10.7 million equity-based offering, according to an SEC filing.

—Ginger Software, a Lexington, MA-based maker of proofreading software, announced on its blog that it had raised $5 million in new funding from Harbor Pacific Capital and Horizons Ventures, as well as $400,000 from previous investors. That makes for a total of $21 million raised by the startup.

—The seven startups RockHealth funded through its inaugural Boston incubator program pitched investors in a demo day last Friday, the same day  TechStarts revealed the 13 companies it will be backing through its fall incubator session.

—Cambridge, MA-based Alnylam Pharmaceuticals inked a 10-year strategic alliance with Monsanto to develop biotech products for the farming industry. Alnylam (NASDAQ: ALNY) will receive $29.2 million upfront as well as potential royalties and milestone payments, in exchange for giving Monsanto exclusive worldwide rights to its RNAi-based technology for agricultural use.

—OmniGuide, a Cambridge-based maker of “advanced energy surgical products” for improving accuracy and control in minimally invasive surgeries, said that it brought in $35 million in non-dilutive funding from an affiliate of OrbiMed Advisors.

—Zafgen raised $3 million in new Series C financing from two investors, the Cambridge-based maker of obesity drugs told Mass High Tech.

By posting a comment, you agree to our terms and conditions.